Skip to content

Daniel D. Von Hoff

The University of Texas at San Antonio Health Science Center

2 papers in the Anchorcite directory, published between 1997 and 2013, cited 12,797 times in total.

ORCID profile

Research topics

Frequent co-authors

  • Malcolm J. Moore · 2 papers
  • Thomas J. Ervin · 1 paper
  • Francis P. Arena · 1 paper
  • Elena Gabriela Chiorean · 1 paper
  • Jeffrey R. Infante · 1 paper
  • Thomas E. Seay · 1 paper
  • Sergei Tjulandin · 1 paper
  • Wen Wee Ma · 1 paper

Papers

  1. Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus GemcitabineNew England Journal of Medicine · 2013 · 6,853 citations

    BACKGROUND: In a phase 1-2 trial of albumin-bound paclitaxel (nab-paclitaxel) plus gemcitabine, substantial clinical activity was noted in patients with advanced pancreatic cancer. We conducted a phase 3 study of the efficacy and safety of the combination versus gemcitabine monotherapy…

  2. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.Journal of Clinical Oncology · 1997 · 5,944 citations

    PURPOSE: Most patients with advanced pancreas cancer experience pain and must limit their daily activities because of tumor-related symptoms. To date, no treatment has had a significant impact on the disease. In early studies with gemcitabine, patients with pancreas cancer…

Metadata from OpenAlex (CC0).